Results 281 to 290 of about 22,236,668 (323)
Some of the next articles are maybe not open access.

Management of hepatorenal syndrome and treatment-related adverse events

Current Medical Research and Opinion
Hepatorenal Syndrome is a critical complication of liver failure, mainly in cirrhotic patients and rarely in patients with acute liver disease. It is a complex spectrum of conditions that leads to renal dysfunction in the liver cirrhosis population; the ...
Lorenzo Peluso   +8 more
semanticscholar   +3 more sources

Treatment Related Adverse Events in Chemotherapy and Their Intervention

International Journal of Clinical Studies and Medical Case Reports, 2021
S. Aldossary
semanticscholar   +2 more sources

Treatment-related adverse events, including fatal toxicities, in patients with solid tumours receiving neoadjuvant and adjuvant immune checkpoint blockade: a systematic review and meta-analysis of randomised controlled trials.

The Lancet Oncology, 2023
BACKGROUND Incorporating immune checkpoint blockade into perioperative cancer therapy has improved clinical outcomes. However, the safety of immune checkpoint blockade needs better evaluation, given the chances of more prolonged disease-free survival. We
Yu Fujiwara   +7 more
semanticscholar   +1 more source

Gastrointestinal Treatment-Related Adverse Events of Combined Immune Checkpoint Inhibitors: A Meta-Analysis

Immunotherapy, 2023
Introduction: Combined immune checkpoint inhibitors can cause gastrointestinal adverse events. Methods: We performed a meta-analysis of pooled colonic, hepatic and pancreatic treatment-related adverse events of combined ICI. Results: 53 trials reporting treatment-related adverse events in 6581 patients.
Rahul Karna   +13 more
openaire   +2 more sources

Hematological immune related adverse events after treatment with immune checkpoint inhibitors.

European Journal of Cancer, 2021
INTRODUCTION With the increasing use of checkpoint inhibitors, rare immune-related adverse events (irAE) are being identified. Haematological irAE (hem-irAE) are difficult to treat and have shown high mortality rates.
Rafaela Kramer   +32 more
semanticscholar   +1 more source

Management of treatment-related adverse events in patients with multiple myeloma

Cancer Treatment Reviews, 2010
The introduction of novel antimyeloma therapies, including thalidomide, lenalidomide and bortezomib, has expanded treatment options for patients with multiple myeloma. These compounds alter the natural history of multiple myeloma and help improve outcomes, but have different and specific toxicity profiles. The major adverse events associated with these
openaire   +2 more sources

Risk factors for treatment‐related adverse events in cancer‐bearing dogs receiving piroxicam

Veterinary and Comparative Oncology, 2016
AbstractPiroxicam has antitumour effects in dogs with cancer, although side effects may limit its use. The purpose of this study was to retrospectively identify factors predisposing cancer‐bearing dogs to adverse events (AEs) following piroxicam therapy.
L R, Eichstadt   +2 more
openaire   +2 more sources

Anxiety and somatic symptoms as predictors of treatment-related adverse events in major depressive disorder

Psychiatry Research, 2004
The purpose of this study was to examine the relationship between the degree of anxiety or somatic symptoms present before treatment with the subsequent diagnosis of treatment-related adverse events (TRAEs) in patients with major depressive disorder (MDD) enrolled in an 8-week open trial of fluoxetine (20 mg).
George I, Papakostas   +5 more
openaire   +2 more sources

Treatment-Related Adverse Events and Outcome in a Clinical Trial of Fluoxetine for Major Depressive Disorder

Annals of Clinical Psychiatry, 2003
Treatment-related adverse events (TRAEs), particularly those that occur early on, may increase the likelihood for premature discontinuation of antidepressants. The purpose of this study was to examine the relationship between TRAEs and outcome in depressed outpatients enrolled in an 8-week, 20 mg, open trial of fluoxetine. A total of 384 patients (54.7%
George I, Papakostas   +6 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy